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Abstract
Background: Yolk sac tumor (YST) is a germ cell neoplasm that arises predominantly in the gonads, but can also
derive from somatic neoplasms in extragonadal locations. These latter cases have been documented in several
organs, although reports from the urinary tract are limited. To our knowledge, this is the first report of a bladder
urothelial carcinoma with a predominant component of YST differentiation.
Case presentation: We present a unique case of a 76-year-old man with a recurrent urinary bladder tumor, initially
interpreted as a high grade urothelial carcinoma with glandular differentiation. In the recurrent tumor, diverse
histological patterns were identified, including glandular, hepatoid and sarcomatoid. This tumor showed positivity
for AFP, GLP3 and SALL4, and negativity for CK7 and EMA. Fluorescent in situ hybridization study showed a
polysomic pattern of chromosome 12. All these findings led to the final diagnosis of a YST derived from urothelial
carcinoma.
Conclusions: YST differentiation should be considered in the differential diagnosis of a high grade urothelial
carcinoma, particularly when glandular and other unusual patterns are observed.
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Background
Yolk sac tumor (YST) is a germ cell neoplasm that arises
predominantly within the gonads, but a significant mi-
nority of cases can be found in extragonadal midline lo-
cations, such as sacrococcygeal region, mediastinum,
retroperitoneum and brain [1]. By the other hand, di-
verse somatic neoplasms may present areas of YST dif-
ferentiation. Some authors denominated this group of
neoplasms as “somatically derived YSTs” (SD-YSTs), and
several cases have been reported, mainly from gastro-
intestinal and gynecologic sites [2]. In contrast, cases of
urothelial carcinoma with YST features are scarce in the
literature, and among those cases, YST differentiation
has not been confirmed with additional studies [3, 4].
Herein, we present a case of a recurrent urinary bladder
neoplasm, initially diagnosed as urothelial carcinoma
with glandular differentiation, which showed multiple
unusual histological patterns, and raised the diagnostic
possibility of a YST differentiation. This report aims to
increase the limited literature available for YSTs derived
from urothelial neoplasms.
Case presentation
A 76-year-old man with previous history of smoking,
type 2 diabetes mellitus, dyslipidemia, high blood pres-
sure and alkaptonuria with ochronotic arthropathy, was
referred to our hospital by edema in lower extremities
and renal dysfunction. Image studies showed a papillary
proliferation in the distal portion of the right ureter. The
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biopsy of this lesion revealed a high grade urothelial car-
cinoma (Fig. 1), and the patient was treated with a right
nephroureterectomy. One year later, the tumor relapsed
and the patient underwent a transurethral resection
(TUR) of a lesion located in the right wall of the bladder.
This sample was diagnosed as a high grade urothelial
carcinoma with extensive glandular differentiation. Dur-
ing the subsequent year, a positron emission tomog-
raphy (18F-FDG PET/CT) showed areas of intense
uptake in the urinary bladder, in multiple pelvic lymph
nodes and in a mass located in the right thoracic wall,
where a surgical trocar was placed during the previous
nephroureterectomy. The patient was submitted to rad-
ical cystectomy, pelvic lymphadenectomy and excision of
the thoracic mass.
The specimen of cystectomy showed a polypoid tumor
of 10 cm diameter filling the lumen of the bladder. The
tumor was implanted on the right wall, involved the
right ureteral meatus and grossly extended into the para-
vesical adipose tissue. Macroscopically, the lesion was
heterogeneous, with extensive necrotic and hemorrhagic
areas. Solid areas with white-tan color were also identi-
fied (Fig. 2a). Microscopically, the tumor exhibited
several components and patterns. First, an epithelial
component, organized in papillary and glandular
structures with tall columnar cells. These cells had clear
cytoplasm and showed infra and supranuclear vacuoles,
resembling endometrium or primitive intestinal epithe-
lium. Second, an epithelial component organized in
trabecular and solid patterns composed of polygonal
cells with wide eosinophilic cytoplasm, central nuclei
and nucleoli, similar to hepatocytes. Third, an undiffer-
entiated stromal component with densely cellular areas
composed of round, blue and small cells, intermingled
Fig. 1 Surgical specimen of previous nephroureterectomy exhibiting a high grade urothelial carcinoma with conventional pattern (HE) (a)
positive for CK7 (b). Interphase between conventional urothelial carcinoma and glandular pattern (HE) (c). Areas with glandular pattern (HE) (d).
CDX2 (e). AFP (f). GLP3 (g). SALL4 (h) in areas with glandular pattern
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with less cellular areas with myxoid stroma and nodules
of chondroid tissue with atypical features. Fourth, an
epithelial component with reticular and microcystic pat-
terns, composed of atypical cells exhibiting intra and
extracellular hyaline globules (Fig. 2b-f). All these com-
ponents were admixed. Only a focal component of con-
ventional urothelial carcinoma was identified in the
neighboring area of the right ureteral meatus.
Immunohistochemistry results are listed in Table 1
and illustrated in Fig. 3. Dual color fluorescent in situ
hybridization (FISH) was performed to explore structural
or numeric alterations in the chromosome 12. We used
the probes 12p13.33 Chr12pTel for the short arm of
chromosome 12 (12p), and SureFISH Chr12CEP for the
centromere (CEP12) (acquired from Agilent Technolo-
gies, CA, USA). According to published methods [5], we
calculated the ratio between 12p/CEP12 signals. A ratio
above 1.5 was considered indicative of an isochromo-
some 12 (i12p), while the presence of 3 to 7 pairs of
12p/CEP12 signals in a single nucleus, in 15% or more
of the 50 tumor cells evaluated, was considered a polyso-
mic pattern of chromosome 12. In this case, the FISH
study showed a polysomic pattern of chromosome 12,
but an i12p was not identified.
The thoracic mass showed a pure glandular prolifera-
tion with morphological and immunohistochemical fea-
tures similar to those observed in the bladder tumor, so
it was considered as a tumoral seeding along the surgical
trocar path. After surgery, the patient received chemo-
therapy cycles with poor response, and several systemic
complications. Pulmonary and brain metastasis were
identified nine months after cystectomy. The patient
died eleven months after diagnosis, and an autopsy was
not performed.
Fig. 2 Surgical specimen of cystectomy showing a macroscopically heterogeneous tumor. Solid areas are marked with*(a). Microscopically the
tumor exhibited an area of glandular pattern with supra and infranuclear vacuoles (b). Area with hepatoid pattern (c). Area with an
undifferentiated sarcomatoid component and focus of chondroid differentiation (HE) (d). Areas with reticular-microcystic pattern exhibiting
hyaline globules (HE) (e-f)
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Discussion and conclusions
In this report we present a unique case of YST differen-
tiation arising from a recurrent urothelial carcinoma in a
76-year-old man. This tumor showed a mixture of
several histologic patterns, including a sarcomatoid com-
ponent, which is extremely infrequent.
According to the evidence available, YSTs may arise
from benign and malignant somatic lesions in several
organs. For example, it is well documented the trans-
formation of benign or malignant ovarian and endomet-
rial tumors into YST [6]. Neoplasms with YST
differentiation have also been observed in the sinonasal
region, where they have been denominated teratocarci-
nosarcoma [7], in the stomach, colon, and lung [8]. YST
differentiation is not recognized as a histological variant
in the current WHO classifications of urothelial carcin-
oma. However, some reports of urinary neoplasms
showing some YST-like features are available in the lit-
erature. The majority of these cases have been summa-
rized in a previous publication by Samaratunga et al. [4],
which included one urothelial carcinoma, and four
Fig. 3 Immunohistochemistry results for the surgical specimen of cystectomy. CK A1/A3 (a). EMA (b). CK7 (c). CDX2 (d). HepPar1 (e). AFP (f). GLP3
(g). SALL4 (h). GLP3 and SALL4 in sarcomatoid areas with chondroid differentiation (i-j)
Table 1 RESULTS OF IMMUNOHISTOCHEMISTRY
Antibody Observation
CK AE1/AE3 Diffusely positive, except in chondroid nodules
CDX2 Positive in glandular areas
Hep Par 1 Positive in hepatoid areas
AFP Diffusely positive, more intense in glandular and
hepatoid areas
GLP3 Diffusely positive, more intense in glandular and
hepatoid areas
SALL 4 Diffusely positive, more intense in glandular and
hepatoid areas
GATA 3 Negative (positive in the initial urothelial component)
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adenocarcinomas of the renal pelvis, all exhibiting hepa-
toid areas and AFP positivity; eight cases of bladder
adenocarcinoma with hepatoid areas, and two cases of
conventional bladder urothelial carcinoma, all of them
showing AFP positivity. Reports of urothelial carcinoma
with SALL4 positive areas are also available [9]. Among
those cases, additional immunochemistry studies have
not been performed to confirm YST differentiation.
McNamee et al. proposed the term “somatically derived
YSTs” [2] to denominate the spectrum of somatic neo-
plasms with YST-like features arising most frequently in
somatic neoplasms, and suggested unification of the ter-
minology between different sites where such neoplasms
occur.
Histologically, our case showed a mixture of diverse
patterns, ranging from classical reticular-microcystic to
sarcomatoid pattern with chondroid differentiation. In-
deed, the most relevant histological characteristic of the
somatic neoplasms with YST differentiation is the identi-
fication of several patterns, which can be grouped in two
categories: the classical ones, which comprise reticular-
microcystic, polyvesicular, vitelline, solid and parietal
patterns, and the special ones, which comprise glandular,
hepatoid and sarcomatoid patterns [1]. The glandular
pattern, also referred to as “enteroblastic”, is the most
frequently observed among somatic neoplasms with YST
differentiation [2], while sarcomatoid pattern is ex-
tremely uncommon [10]. In addition to the morphologic
features, the diagnosis of YST differentiation requires
confirmation with a characteristic immunohistochemis-
try profile. A majority of these neoplasms shows positiv-
ity for AFP, SALL4, and negativity for differentiated
epithelial markers, such as CK7 and EMA [2]. CDX2 is
usually positive in areas with glandular pattern, while
hepatic differentiation markers, such as HepPar 1, may
be positive in hepatoid areas. Our case showed the de-
scribed immunohistochemistry profile, in agreement
with the diagnosis of YST differentiation. Moreover, im-
munohistochemistry performed in previous biopsy speci-
mens, showed similar results in the areas with glandular
differentiation (Fig. 1e-h).
We identified genetic alterations in the short arm of
chromosome 12, which showed a polysomic pattern, but
an i12p was not identified. The polysomic pattern of 12p
abnormality has been described previously in germ cell
tumors of the central nervous system, although it is of
unknown significance [5]. Chromosome 12 abnormal-
ities, either as an i12p or as 12p overrepresentation, are
the hallmark cytogenetic alteration of germ cell tumors.
These alterations are identified in the majority of go-
nadal germ cell tumors, with few exceptions [11], and in
somatic type malignancies, derived from germ cell tu-
mors. However, the occurrence of chromosome 12 ab-
normalities is not well established in somatic neoplasms
with YST differentiation. While some authors identified
i12p and other alterations of chromosome 12 [12], other
authors reported cases without i12p, arguing that their
results were consistent with the possible somatic origin
of the YST component in these neoplasms [10]. The
contradictory results may be due to problems in inter-
pretation of the FISH, which is a common assay to iden-
tify i12p, but can be difficult to evaluate, and lacks of
ideal sensitivity and specificity [13]. Also, the results may
be explained by uncertainties regarding the actual origin
of the neoplastic cells in somatic tumors with YST dif-
ferentiation, which may derive from somatic neoplastic
cells through a process of retrodifferentiation or neome-
taplasia, or from a pluripotential embryonic stem/germ
cell [2]. Currently, further investigation is required to
better characterize genetic alterations in YSTs derived
from somatic neoplasms, and to elucidate their actual
histogenesis.
Our patient had some clinical characteristics described
previously among patients with urinary tumors exhibit-
ing YST features. According to the available reports [4],
these tumors are more frequently diagnosed among men
of 73 years-old on average, thus differing from primary
extragonadal YST that are more common in young pa-
tients. Elevated serum Alphafetoprotein (AFP) levels
may be also observed among these patients. Regarding
our case, these levels were not determined, because this
enzyme is not routinely measured in post-surgical con-
trols of adult patients with a bladder carcinoma. How-
ever, AFP serum levels should be determined in patients
with urothelial neoplasms exhibiting infrequent histo-
logical patterns (e.g. glandular or hepatoid), because the
elevation of these levels support the diagnosis of YST
differentiation. Moreover, these determinations may be
used to control the postsurgical evolution, and to detect
tumor relapse among these patients [14].
Differential diagnosis included metastatic YST from
the testicles, primary extragonadal YST, sarcomatoid
urothelial carcinoma, chordoid urothelial carcinoma
[15], and carcinoma with enteroblastic or hepatoid dif-
ferentiation. Metastatic YST and primary extragonadal
YST of the bladder are extremely infrequent, and were
ruled out after the revision of previous biopsies from the
same anatomical location, which showed a primary
tumor comprised of conventional urothelial carcinoma
admixed with areas of glandular differentiation (Fig. 1a-
d). These latter areas were morphologically and histo-
chemically similar to the glandular component of the
cystectomy specimen, supporting the diagnosis of
urothelial carcinoma with YST differentiation. Sarcoma-
toid and chordoid urothelial carcinoma were excluded
after the identification of areas with classical YST pat-
tern and immunohistochemistry results. Carcinoma with
enteroblastic differentiation has been reported in several
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organs (gastrointestinal, lung, etc) [16], while carcinoma
with hepatoid differentiation has been mainly reported
in gynecologic tumors [17], and in urinary tract tumors
already mentioned [4]. These neoplasms show some
histologic and immunohistochemical features, similar to
those identified in our case. As previously discussed, ac-
cording to some authors [2], tumors with enteroblastic
and/or hepatoid differentiation could be considered part
of the wide spectrum of the so-called SD-YSTs.
In summary, this is a unique case of a bladder
urothelial carcinoma with YST differentiation, showing
multiple and complex histological patterns. YST differ-
entiation should be suspected in adult patients with ex-
tragonadal somatic tumors, also urothelial carcinoma,
exhibiting diverse histological patterns, particularly glan-
dular and hepatoid. The diagnosis of YST differentiation
in somatic neoplasms requires confirmation with immu-
nohistochemistry results, which necessarily include posi-
tivity for AFP, GLP3 and SALL4, and negativity for
epithelial markers like CK7 and EMA. Elevated AFP
serum levels may support the diagnosis, when this deter-
mination is available.
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